Steven E. Finkelstein, MD, FACRO presented “Embracing a New Normal of Innovation: Radiation Oncology Advances in Precision Diagnosis and Treatment for Prostate Cancer” during the 7th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on September 22, 2023.
How to cite: Finkelstein, Steven E. “Embracing a New Normal of Innovation: Radiation Oncology Advances in Precision Diagnosis and Treatment for Prostate Cancer.” September 22, 2023. Accessed Nov 2024. https://grandroundsinurology.com/embracing-a-new-normal-of-innovation-radiation-oncology-advances-in-precision-diagnosis-and-treatment-for-prostate-cancer/
Embracing a New Normal of Innovation: Radiation Oncology Advances in Precision Diagnosis and Treatment for Prostate Cancer – Summary
Steven E. Finkelstein, MD, FACRO, examines the advances in radiation oncology that are reshaping precision diagnosis and treatment for prostate cancer. He highlights how recent technological developments have enhanced both the accuracy and effectiveness of radiation therapy.
Dr. Finkelstein discusses cutting-edge imaging techniques such as multiparametric MRI and PET/CT scans, which enable clinicians to precisely delineate tumor boundaries and identify regions of aggressive disease. He also explores advancements in radiation delivery techniques, including intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT).
The presentation addresses the role of artificial intelligence (AI) and machine learning in revolutionizing radiation oncology. AI algorithms are being developed to assist in treatment planning, predict patient responses, and adapt therapies based on tumor changes. These technologies promise to streamline workflows, reduce planning times, and enhance the precision of radiation delivery.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Steven E. Finkelstein, MD, FACRO, is the Director of the Center of Advanced Radiation Excellence, and Director of Radiation Oncology Research for Associated Medical Professionals in Syracuse, New York. His interests include the research of a variety of cancers, busting radiation driven, and personalized systemic therapy. He holds three international patents in the field of cutting edge technologies.
Dr. Finkelstein received his medical degree from the University of Michigan Medical School, graduating cum laude eruditions causa. He then joined the National Cancer Institute, National Institutes of Health as Clinical Associate. He completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship, and an additional radiation oncology residency.
He served a residency in General Surgery at Washington University in Saint Louis, Missouri, Dr. Finkelstein also served fellowships in Biologic Immunotherapy, Clinical Cancer, and Surgical Oncology at the Surgery Branch of the National Cancer Institute in Bethesda, Maryland. He is a member of the American College of Radiation Oncology, the American Medical Association, the American Society of Clinical Oncology, the American Society for Therapeutic Radiology and Oncology, the Radiological Society of North America, and the Radiation Therapy Oncology Group.
He has served as a Co-Chair on the NRG Immunotherapy Committee, Co-Chair of the 2018-2019 ACRO Scientific Program Committee, and Chair of the SWOG Radiation STG Committee. He currently serves on the Board of Chancellors for ACRO. Dr. Finkelstein has also served as National Director of Translational Research Consortium (TRC), the cutting-edge therapy arm of 21st Century Oncology in Scottsdale, Arizona. Inspired by his grandmother, a cancer patient, he became a dedicated cancer surgeon who found that radiation therapy could sometimes do for his patients what surgery could not.
